Mizuho lowered the firm’s price target on Pediatrix Medical to $11 from $15 and keeps a Neutral rating on the shares. The company reported an EBITDA miss as volume was challenging in the quarter and labor costs worsened sequentially, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MD:
